[Clinical experiences with solu-supronal with special reference to coli infections in cystitis and prostate hypertrophy].
D003556:Cystitis / Q000628:therapy*; D004338:Drug Combinations; D004926:Escherichia coli; D004927:Escherichia coli Infections; D006801:Humans; D006984:Hypertrophy; D008297:Male; D011470:Prostatic Hyperplasia / Q000628:therapy*; D013411:Sulfadiazine; D013449:Sulfonamides / Q000627:therapeutic use*; D013890:Thiourea / Q000031:analogs & derivatives
D004338:Drug Combinations; D013449:Sulfonamides; D013411:Sulfadiazine; C009364:supronal; D013890:Thiourea
CYSTITIS/therapy; ESCHERICHIA COLI/infections; PROSTATE HYPERTROPHY/therapy; SULFONAMIDES/therapeutic use
Klinische Erfahrungen mit Solu-Supronal unter besonderer Berücksichtigung der Koliinfektionen bei Cystitis und Prostatahypertrophie.